NCT00003210
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +51 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Explore clinical trials studying Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
58 public trials
1 recruiting study
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma trial results
NCT01158274
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +151 more
- Locations
-
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT00499811
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- National Institutes of Health Bethesda, Maryland, United States
NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00293345
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00348985
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
- Locations
-
- University of Colorado Denver, Colorado, United States
NCT00004241
- Conditions
- AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +105 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States